ModelEdge

Chromocell Therapeutics
CHRO
Filing Type8-K
Filing Date1/12/2026
Updated1/13/26, 6:30 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Reg. FD
EX-4.1EXHIBIT 4.1
EX-10.1EXHIBIT 10.1
EX-99.1Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Reg. FD
GRAPHICGraphic